Francisco Partners - News - AndHealth, the Digital Health Company for Reversing Migraine and Autoimmune Diseases, Raises $57 Million in Financing for Growth
Summary
“Just like the best employers recognized with mental health beginning five or so years ago, there is a growing consensus that it is now time to destigmatize migraine and improve access to care so that people can reclaim their lives from this disease,” said AndHealth CEO, Matt Scantland. Typically, these are the conditions that are associated with the most pain and life disruption, versus diseases that are only experienced as ‘numbers’ early in their progression, such as hypertension, pre-diabetes and hyperlipidemia.” The rationale for this position is rooted in the science of systems biology. At the conclusion of the study, 60 percent of the participants experienced improvement significant enough that they no longer met the ICHD-3 diagnostic criteria for migraine, demonstrating profound hope for the millions of sufferers who haven’t had adequate treatment options. According to AndHealth national virtual practice Medical Director, Dr. Robert Darling, former White House physician for the Clinton administration and leading expert in telehealth, “This patient’s experience is not at all unusual. Headquartered on Sand Hill Road in Menlo Park, CA, with additional offices in Chicago, IL and Columbus, OH, Health2047 Capital Partners is the sister company of Health2047 Inc., the Silicon Valley-based innovation subsidiary of the American Medical Association (AMA).